Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Cervical Cancer

Free Subscription Articles published in Int J Gynecol Cancer Retrieve available abstracts of 249 articles: HTML format

Single Articles

July 2024
1. LINDEGAARD JC, Petric P, Tan LT, Hoskin P, et al
   Are we making progress in curing advanced cervical cancer-again?
   Int J Gynecol Cancer. 2024 Jul 10:ijgc-2024-005572.
   PubMed     Abstract available
   
   
   
2. VAN DEN BERG MC, Berg HF, Stokowy T, Hoivik EA, et al
   Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2.
   Int J Gynecol Cancer. 2024;34:993-1000.
   PubMed     Abstract available
   
   
   
3. FRUHAUF F, Cibula D, Kocian R, Zikan M, et al
   Diagnostic performance of ultrasonography in pre-operative assessment of lymph nodes in patients with cervical cancer.
   Int J Gynecol Cancer. 2024;34:985-992.
   PubMed     Abstract available
   
   
   June 2024
4. AKYILDIZ A, Gultekin M, Yigit E, Demir E, et al
   Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group.
   Int J Gynecol Cancer. 2024 Jun 30:ijgc-2024-005419.
   PubMed     Abstract available
   
   
   
5. AGUSTI N, Viveros-Carreno D, Melamed A, Pareja R, et al
   Adjuvant external beam radiotherapy combined with brachytherapy for intermediate-risk cervical cancer.
   Int J Gynecol Cancer. 2024 Jun 25:ijgc-2024-005570.
   PubMed     Abstract available
   
   
   
6. GUO XM, Roman LD, Matsuo K
   Considerations for route of hysterectomy in low-risk cervical cancer.
   Int J Gynecol Cancer. 2024 Jun 23:ijgc-2024-005745.
   PubMed    
   
   
   
7. SALANI R, McCormack M, Kim YM, Ghamande S, et al
   A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04).
   Int J Gynecol Cancer. 2024 Jun 10:ijgc-2024-005588.
   PubMed     Abstract available
   
   
   
8. DIGGS A, Huang Y, Melamed A, Szamreta E, et al
   Patterns of use of primary and first-line chemotherapy for recurrence among patients with cervical cancer.
   Int J Gynecol Cancer. 2024 Jun 8:ijgc-2023-004860. doi: 10.1136/ijgc-2023-004860
   PubMed     Abstract available
   
   
   
9. PAREJA R
   Vaginal radical trachelectomy: is now the end of an era?
   Int J Gynecol Cancer. 2024;34:806-807.
   PubMed    
   
   
   May 2024
10. NISTOR SI, El Tawab S, Zouridis A, Ferrari F, et al
    Minimally invasive surgery in the management of early stage cervical cancer after the publication of SHAPE trial.
    Int J Gynecol Cancer. 2024 May 31:ijgc-2024-005724.
    PubMed    
    
    
    April 2024
11. SHI V, Grover S, Huang Y, Thaker PH, et al
    Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation.
    Int J Gynecol Cancer. 2024 Apr 29:ijgc-2024-005303.
    PubMed     Abstract available
    
    
    
12. CHARNALIA M, Chopra S, Mulani J, Popat P, et al
    RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials.
    Int J Gynecol Cancer. 2024 Apr 22:ijgc-2024-005336.
    PubMed     Abstract available
    
    
    
13. ROSATI A, Certelli C, Ferrandina G, Fanfani F, et al
    Minimally invasive adrenalectomy: a personalized surgical approach in recurrent cervical cancer.
    Int J Gynecol Cancer. 2024 Apr 22:ijgc-2023-005241.
    PubMed    
    
    
    
14. KOHLER C, Plaikner A, Siegler K, Hertel H, et al
    Radical vaginal trachelectomy: long-term oncologic and fertility outcomes in patients with early cervical cancer.
    Int J Gynecol Cancer. 2024 Apr 10:ijgc-2024-005274.
    PubMed     Abstract available
    
    
    
15. HANEY K, Ismail-Pratt I, Ng JS, Schmeler KM, et al
    The International Gynecologic Cancer Society Preinvasive Certificate Program: building a skilled workforce for the detection and treatment of cervical pre-cancer.
    Int J Gynecol Cancer. 2024;34:637-638.
    PubMed    
    
    
    
16. KEMAH BL, Bhagat N, Pandya A, Sullivan R, et al
    Training the gynecologic oncologists of the future - challenges and opportunities.
    Int J Gynecol Cancer. 2024;34:619-626.
    PubMed     Abstract available
    
    
    March 2024
17. WESS B, Kohler C, Plaikner A, El-Safadi S, et al
    Comparative study using indocyanine green and patent blue dye for sentinel lymph node biopsy in patients with early-stage cervical cancer.
    Int J Gynecol Cancer. 2024 Mar 14:ijgc-2023-005206.
    PubMed     Abstract available
    
    
    
18. DEL M, Illac C, Morisseau M, Angeles MA, et al
    Intraepithelial tumor-infiltrating lymphocytes shape loco-regional PET/CT spread of locally advanced cervical cancer.
    Int J Gynecol Cancer. 2024 Mar 12:ijgc-2023-004677.
    PubMed     Abstract available
    
    
    
19. JAYRAJ AS, Singhal S
    The beginning of the end for cervical cancer in India.
    Int J Gynecol Cancer. 2024 Mar 7:ijgc-2024-005420. doi: 10.1136/ijgc-2024-005420
    PubMed    
    
    
    
20. VIVEROS-CARRENO D, Pareja R, Plante M
    De-escalation of surgical radicality for non-fertility preserving management in patients with early-stage cervical cancer: a systematic review.
    Int J Gynecol Cancer. 2024;34:386-392.
    PubMed     Abstract available
    
    
    
21. PETERS I, Marchetti C, Scambia G, Fagotti A, et al
    New windows of surgical opportunity for gynecological cancers in the era of targeted therapies.
    Int J Gynecol Cancer. 2024;34:352-362.
    PubMed     Abstract available
    
    
    February 2024
22. FOTOPOULOU C, Eriksson AG, Planchamp F, Morice P, et al
    European Society of Gynaecological Oncology expanded quality indicators and accreditation for cervical cancer management.
    Int J Gynecol Cancer. 2024 Feb 23:ijgc-2024-005293.
    PubMed    
    
    
    
23. BIZZARRI N, Obermair A, Hsu HC, Chacon E, et al
    Consensus on surgical technique for sentinel lymph node dissection in cervical cancer.
    Int J Gynecol Cancer. 2024 Feb 20:ijgc-2023-005151.
    PubMed     Abstract available
    
    
    
24. VAZQUEZ-VICENTE D, Boria F, Castellanos T, Gutierrez M, et al
    SUCCOR morbidity: complications in minimally invasive versus open radical hysterectomy in early cervical cancer.
    Int J Gynecol Cancer. 2024;34:203-208.
    PubMed     Abstract available
    
    
    January 2024
25. LAAN J, van Lonkhuijzen L, Hinnen K, Pieters B, et al
    Malnutrition is associated with poor survival in women receiving radiotherapy for cervical cancer.
    Int J Gynecol Cancer. 2024 Jan 17:ijgc-2023-005024.
    PubMed     Abstract available
    
    
    December 2023
26. RIBEIRO R, Baiocchi G, Moretti-Marques R, Linhares JC, et al
    Uterine transposition for fertility and ovarian function preservation after radiotherapy.
    Int J Gynecol Cancer. 2023;33:1837-1842.
    PubMed     Abstract available
    
    
    
27. PARPINEL G, Laas-Faron E, Balaya V, Guani B, et al
    Survival after sentinel lymph node biopsy for early cervical cancers: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2023;33:1853-1860.
    PubMed     Abstract available
    
    
    
28. PLAIKNER A, Siegler K, Kohler C
    Surgical steps of laparoscopic-assisted simple vaginal trachelectomy.
    Int J Gynecol Cancer. 2023;33:1972-1973.
    PubMed    
    
    
    November 2023
29. BORGHI C, Biagioli E, Mauro J, Roberto A, et al
    Neoadjuvant chemotherapy prior to radical hysterectomy in locally advanced cervical cancer: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2023 Nov 27:ijgc-2023-004863.
    PubMed     Abstract available
    
    
    
30. CARUSO G, Bruni S, Lapresa M, De Vitis LA, et al
    Dose-dense neoadjuvant chemotherapy before radical surgery in cervical cancer: a retrospective cohort study and systematic literature review.
    Int J Gynecol Cancer. 2023 Nov 10:ijgc-2023-004928.
    PubMed     Abstract available
    
    
    
31. PARIDA P, Baburaj G, Rao M, Lewis S, et al
    Circulating cell-free DNA as a diagnostic and prognostic marker for cervical cancer.
    Int J Gynecol Cancer. 2023 Nov 10:ijgc-2023-004873.
    PubMed     Abstract available
    
    
    
32. KOUHEN F, El Ghanmi A
    Breaking the silence: the taboo surrounding HPV vaccination in Morocco.
    Int J Gynecol Cancer. 2023;33:1835.
    PubMed    
    
    
    
33. NITECKI R, Ramirez PT, Dundr P, Nemejcova K, et al
    MILACC study: could undetected lymph node micrometastases have impacted recurrence rate in the LACC trial?
    Int J Gynecol Cancer. 2023;33:1684-1689.
    PubMed     Abstract available
    
    
    
34. ALLANSON ER, Burling M, Simcock B, Nicklin J, et al
    The Australian Society of Gynaecological Oncology Western Pacific Liaison group.
    Int J Gynecol Cancer. 2023;33:1819-1820.
    PubMed    
    
    
    October 2023
35. SALCEDO MP, Lathrop E, Osman N, Neves A, et al
    The Mulher Study: cervical cancer screening with primary HPV testing in Mozambique.
    Int J Gynecol Cancer. 2023 Oct 31:ijgc-2023-004958.
    PubMed     Abstract available
    
    
    
36. XIA L, Wang J, Wang C, Zhang Q, et al
    Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: a multicenter, single-arm, phase II study.
    Int J Gynecol Cancer. 2023 Oct 24:ijgc-2023-004705.
    PubMed     Abstract available
    
    
    
37. FRUMOVITZ M, Morani AC, Aziz A, Jhingran A, et al
    PET/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: a NeCTuR study.
    Int J Gynecol Cancer. 2023 Oct 24:ijgc-2023-004907.
    PubMed     Abstract available
    
    
    
38. MBURU A, Shaffi AF
    Pathological pelvic fracture due to metastatic cervical cancer in a young immunosuppressed woman.
    Int J Gynecol Cancer. 2023 Oct 19:ijgc-2023-004479.
    PubMed    
    
    
    September 2023
39. BIZZARRI N, Russo L, Dolciami M, Zormpas-Petridis K, et al
    Radiomics systematic review in cervical cancer: gynecological oncologists' perspective.
    Int J Gynecol Cancer. 2023 Sep 15:ijgc-2023-004589.
    PubMed     Abstract available
    
    
    
40. PLAIKNER A, Siegler K, Hertel H, Jacob A, et al
    Fertility sparing therapy in women with lymph node negative cervical cancer >2cm - oncologic and fertility outcomes of neoadjuvant chemotherapy followed by radical vaginal trachelectomy.
    Int J Gynecol Cancer. 2023 Sep 11:ijgc-2023-004669.
    PubMed     Abstract available
    
    
    
41. TURCO LC, Pedone Anchora L, Scambia G, Ferrandina G, et al
    Response to: Correspondence on "Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery" by Yuce Sari et al.
    Int J Gynecol Cancer. 2023;33:1491-1492.
    PubMed    
    
    
    
42. YUCE SARI S, Bay M, Gultekin M
    Correspondence on 'Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery' by Turco et al.
    Int J Gynecol Cancer. 2023;33:1490.
    PubMed    
    
    
    
43. NAKISIGE C, de Fouw M, Kabukye J, Sultanov M, et al
    Artificial intelligence and visual inspection in cervical cancer screening.
    Int J Gynecol Cancer. 2023 Sep 4:ijgc-2023-004397. doi: 10.1136/ijgc-2023-004397
    PubMed     Abstract available
    
    
    
44. SALVO G, Flores Legarreta A, Ramalingam P, Jhingran A, et al
    Clinicopathologic characteristics, oncologic outcomes, and prognostic factors in neuroendocrine cervical carcinoma: a Neuroendocrine Cervical Tumor Registry study.
    Int J Gynecol Cancer. 2023;33:1359-1369.
    PubMed     Abstract available
    
    
    
45. MICHAAN N, Wenkert A, Even-Sapir E, Kerzhner K, et al
    Prognostic significance of delayed complete metabolic response on PET/CT after primary chemoradiation treatment of cervical cancer.
    Int J Gynecol Cancer. 2023 Sep 1:ijgc-2023-004703. doi: 10.1136/ijgc-2023-004703
    PubMed     Abstract available
    
    
    August 2023
46. MAURO J, Viveros-Carreno D, Vizzielli G, De Ponti E, et al
    Survival after sentinel node biopsy alone in early-stage cervical cancer: a systematic review.
    Int J Gynecol Cancer. 2023 Aug 16:ijgc-2023-004692.
    PubMed     Abstract available
    
    
    
47. GONZALEZ-OCHOA E, Milosevic M, Corr B, Abbruzzese JL, et al
    A phase I study of the Wee1 kinase inhibitor adavosertib (AZD1775) in combination with chemoradiation in cervical, upper vaginal, and uterine cancers.
    Int J Gynecol Cancer. 2023;33:1208-1214.
    PubMed     Abstract available
    
    
    July 2023
48. BOGANI G, Ghelardi A, Sopracordevole F, Annoni M, et al
    Human papillomavirus (HPV) vaccination: a call for action in Italy.
    Int J Gynecol Cancer. 2023;33:1132-1139.
    PubMed     Abstract available
    
    
    June 2023
49. OBERMAIR A, Leitao M
    Correspondence on "ESGO/ESTRO/ESP guidelines fpr the management of patients with cervical cancer: update 2023" by Cibula et al.
    Int J Gynecol Cancer. 2023 Jun 15:ijgc-2023-004645.
    PubMed    
    
    
    
50. PAREJA R, Heredia F, Leitao M
    Correspondence on 'ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023*'.
    Int J Gynecol Cancer. 2023 Jun 9:ijgc-2023-004656. doi: 10.1136/ijgc-2023-004656
    PubMed    
    
    
    
51. KOBAYASHI E, Takekuma M, Enomoto T, Okamoto A, et al
    Response to: Commentary on "Surgical skill and oncological outcome of laparoscopic radical hysterectomy: JGOG1081S-A1, an ancillary analysis of the Japanese Gynecologic Oncology Group Study JGOG1081" by Ramirez et al.
    Int J Gynecol Cancer. 2023;33:1012.
    PubMed    
    
    
    
52. CORDOBA A, El Hajj H, Martinez-Gomez C, Hudry D, et al
    Should the cut-off for concomitant radiochemotherapy and intracavitary 3D adaptive uterovaginal brachytherapy be 3 cm?
    Int J Gynecol Cancer. 2023;33:1010-1011.
    PubMed    
    
    
    
53. CASTILLO MH, Rodriguez R, Chavez C, Baltazar D, et al
    Control and management of gynecological cancer in Peru.
    Int J Gynecol Cancer. 2023;33:995-996.
    PubMed    
    
    
    
54. NGUYEN CGT, Phillips S, Chen A, Harrison R, et al
    Isolated tumor cells in a patient with early-stage cervical cancer.
    Int J Gynecol Cancer. 2023 Jun 2:ijgc-2022-004115. doi: 10.1136/ijgc-2022-004115
    PubMed    
    
    
    May 2023
55. CHARGARI C, Tanderup K, Planchamp F, Chiva L, et al
    ESGO/ESTRO quality indicators for radiation therapy of cervical cancer.
    Int J Gynecol Cancer. 2023 May 31:ijgc-2022-004180.
    PubMed     Abstract available
    
    
    
56. ZHANG X, Wang Y, Lv X, Wang F, et al
    Intratumoral injection of oncolytic virus (H101) in combination with concurrent chemoradiotherapy for locally advanced cervical cancer.
    Int J Gynecol Cancer. 2023 May 19:ijgc-2022-003914.
    PubMed     Abstract available
    
    
    
57. VIVEROS-CARRENO D, Vieira-Serna S, Grillo-Ardila CF, Rodriguez J, et al
    Definitive pelvic radiotherapy for patients with newly diagnosed stage IVB cervical cancer: a systematic review.
    Int J Gynecol Cancer. 2023 May 16:ijgc-2023-004465.
    PubMed     Abstract available
    
    
    
58. CIBULA D, Raspollini MR, Planchamp F, Centeno C, et al
    ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
    Int J Gynecol Cancer. 2023;33:649-666.
    PubMed     Abstract available
    
    
    
59. ISHIKAWA M, Shibata T, Kataoka T, Takekuma M, et al
    Final analysis of a randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinom
    Int J Gynecol Cancer. 2023;33:692-700.
    PubMed     Abstract available
    
    
    
60. PELEG HASSON S, Felder S, Helpman L, Taylor A, et al
    Outcomes associated with treatment to all sites of disease in patients with stage IVB cancer of the cervix.
    Int J Gynecol Cancer. 2023;33:683-691.
    PubMed     Abstract available
    
    
    
61. CUSCHIERI K, Fellner MD, Arroyo Muhr LS, Padalko E, et al
    Quality assurance in human papillomavirus testing for primary cervical screening.
    Int J Gynecol Cancer. 2023;33:802-811.
    PubMed     Abstract available
    
    
    
62. LEVYTSKA K, Pena SR, Brown J, Yu Z, et al
    Opioid and benzodiazepine use in gynecologic oncology patients.
    Int J Gynecol Cancer. 2023;33:786-791.
    PubMed     Abstract available
    
    
    April 2023
63. BUDA A, Fanfani F
    The patterns of growth of cervical cancer: a challenge to personalized radical surgery.
    Int J Gynecol Cancer. 2023 Apr 25:ijgc-2023-004556.
    PubMed    
    
    
    
64. RAMIREZ PT
    ESGO/ESTRO/ESP updated guidelines in cervical cancer.
    Int J Gynecol Cancer. 2023 Apr 13:ijgc-2023-004523.
    PubMed    
    
    
    
65. SAGAE S, Toita T, Matsuura M, Saito M, et al
    Improvement in radiation techniques for locally advanced cervical cancer during the last two decades.
    Int J Gynecol Cancer. 2023 Apr 11:ijgc-2022-004230.
    PubMed     Abstract available
    
    
    
66. TOUHAMI O, Plante M, St-Gelais J, Frumovitz M, et al
    Association of nivolumab and niraparib in the management of neuroendocrine cancer of the cervix.
    Int J Gynecol Cancer. 2023;33:623-627.
    PubMed    
    
    
    
67. KESIC V, Carcopino X, Preti M, Vieira-Baptista P, et al
    The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus s
    Int J Gynecol Cancer. 2023;33:446-461.
    PubMed     Abstract available
    
    
    
68. KAMANI MO, Kyrgiou M, Joura E, Zapardiel I, et al
    ESGO Prevention Committee opinion: is a single dose of HPV vaccine good enough?
    Int J Gynecol Cancer. 2023;33:462-464.
    PubMed    
    
    
    
69. GOMEZ CHEREY JF, Payalef SN, Fleider L, Reyes AP, et al
    Microbiota unbalance in relation to high-risk human papillomavirus cervical infection.
    Int J Gynecol Cancer. 2023;33:482-488.
    PubMed     Abstract available
    
    
    
70. BOCCIOLONE L, Candotti G, Cioffi R, Rabaiotti E, et al
    Sentinel lymph node biopsy in open surgery for gynecological malignancies.
    Int J Gynecol Cancer. 2023;33:636-637.
    PubMed    
    
    
    March 2023
71. SOOCHIT A, Zhang C, Feng Y, Luo X, et al
    Impact of different post-operative treatment modalities on long-term outcomes in International Federation of Gynecology and Obstetrics (FIGO) 2018 stage IIICp cervical cancer.
    Int J Gynecol Cancer. 2023 Mar 31:ijgc-2022-004234.
    PubMed     Abstract available
    
    
    
72. CAPOZZI VA, Rotondella I, De Finis A, Scarpelli E, et al
    Rectovaginal fistula repair by Martius flap after exclusive chemoradiation in a patient with advanced cervical cancer.
    Int J Gynecol Cancer. 2023 Mar 23:ijgc-2023-004365.
    PubMed    
    
    
    
73. OBERMAIR A, Pareja R
    Can simple hysterectomy replace radical hysterectomy as treatment of early-stage cervical cancer?
    Int J Gynecol Cancer. 2023 Mar 10:ijgc-2023-004372.
    PubMed    
    
    
    
74. VIVEROS-CARRENO D, Fernandes A, Pareja R
    Updates on cervical cancer prevention.
    Int J Gynecol Cancer. 2023;33:394-402.
    PubMed     Abstract available
    
    
    
75. GRAU JF, Farinas-Madrid L, Garcia-Duran C, Garcia-Illescas D, et al
    Advances in immunotherapy in cervical cancer.
    Int J Gynecol Cancer. 2023;33:403-413.
    PubMed     Abstract available
    
    
    
76. CHELARIU-RAICU A, Mahner S, Moore KN, Lorusso D, et al
    Integrating antibody drug conjugates in the management of gynecologic cancers.
    Int J Gynecol Cancer. 2023;33:420-429.
    PubMed     Abstract available
    
    
    February 2023
77. WEYL A, Chollet C, Gabiache E, Cances-Lauwers V, et al
    PET-MRI for evaluation of response to radiochemotherapy in patients with locally advanced cervical cancer.
    Int J Gynecol Cancer. 2023 Feb 23:ijgc-2022-003958.
    PubMed     Abstract available
    
    
    
78. ROBINSON EF, Darby JP, Moulder JK
    Cervical cancer screening: missed opportunities in a one-track model.
    Int J Gynecol Cancer. 2023 Feb 7:ijgc-2023-004311. doi: 10.1136/ijgc-2023-004311
    PubMed    
    
    
    
79. CHARGARI C, Nout RA, Lindegaard J, Morice P, et al
    Can we improve survival with less overall morbidity for patients with intermediate-risk cervical cancer without the use of external beam radiotherapy?
    Int J Gynecol Cancer. 2023 Feb 7:ijgc-2023-004305. doi: 10.1136/ijgc-2023-004305
    PubMed    
    
    
    
80. 
    Correction: SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer.
    Int J Gynecol Cancer. 2023;33:316.
    PubMed    
    
    
    
81. 
    Correction: The increasing incidence of stage IV cervical cancer in the USA: what factors are related?
    Int J Gynecol Cancer. 2023;33:317-318.
    PubMed    
    
    
    
82. ZAPARDIEL I, Ceccaroni M, Minig L, Halaska MJ, et al
    Avascular spaces in radical hysterectomy.
    Int J Gynecol Cancer. 2023;33:285-292.
    PubMed     Abstract available
    
    
    January 2023
83. TURCO LC, Pedone Anchora L, Fedele C, Inzani F, et al
    Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery.
    Int J Gynecol Cancer. 2023 Jan 31:ijgc-2022-003940.
    PubMed     Abstract available
    
    
    
84. MARTINEZ A, Lecuru F, Bizzarri N, Chargari C, et al
    PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study.
    Int J Gynecol Cancer. 2023 Jan 30:ijgc-2022-004223.
    PubMed     Abstract available
    
    
    
85. CARNEIRO VCG, Batista TP, Andrade MR, Barros AV, et al
    Proof-of-concept randomized phase II non-inferiority trial of simple versus type B2 hysterectomy in early-stage cervical cancer
    Int J Gynecol Cancer. 2023 Jan 25:ijgc-2022-004092.
    PubMed     Abstract available
    
    
    
86. CHIVA L, Gonzalez-Rodriguez M, Tendobi C
    Elikia: a hope for cervical cancer in the Democratic Republic of Congo.
    Int J Gynecol Cancer. 2023 Jan 17:ijgc-2022-004220.
    PubMed    
    
    
    
87. SNYMAN LC, Richter KL, Lukhwareni A, Dreyer G, et al
    Cytology compared with Hybrid Capture 2 human papilloma virus cervical cancer screening in HIV positive and HIV negative South African women.
    Int J Gynecol Cancer. 2023 Jan 17:ijgc-2022-003897.
    PubMed     Abstract available
    
    
    December 2022
88. ROBLES-MORALES R, Morril KE, Lopez-Pentecost M, Madhivanan P, et al
    Arizona-Sonora binational data sharing: the missing piece to the cervical cancer puzzle.
    Int J Gynecol Cancer. 2022 Dec 21:ijgc-2022-004181.
    PubMed    
    
    
    
89. SUZUKI Y, Huang Y, Ferris J, Kulkarni A, et al
    Prescription of hormone replacement therapy among cervical cancer patients with treatment-induced premature menopause.
    Int J Gynecol Cancer. 2022 Dec 21:ijgc-2022-003861.
    PubMed     Abstract available
    
    
    
90. CHEN Y, Zheng Y, Wang Q, Dai S, et al
    Transumbilical laparoendoscopic single-site radical trachelectomy with uterine arteries' ascending branches preservation for early-stage cervical cancer.
    Int J Gynecol Cancer. 2022 Dec 16:ijgc-2022-003887.
    PubMed    
    
    
    
91. 
    Correction: The increasing incidence of stage IV cervical cancer in the USA: what factors are related?
    Int J Gynecol Cancer. 2022;32:1635.
    PubMed    
    
    
    
92. LEJEUNE C, Trozzi R, Mearadji B, Painter R, et al
    Successful cervical cancer treatment during a monochorionic diamniotic twin pregnancy in a patient with history of preterm delivery.
    Int J Gynecol Cancer. 2022;32:1611-1614.
    PubMed    
    
    
    
93. BAE BK, Cho WK, Kim BG, Choi CH, et al
    Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification.
    Int J Gynecol Cancer. 2022;32:1524-1530.
    PubMed     Abstract available
    
    
    
94. HOEGL J, Viveros-Carreno D, Palacios T, Gallego-Ardila A, et al
    Peritoneal carcinomatosis after minimally invasive surgery versus open radical hysterectomy: systematic review and meta-analysis.
    Int J Gynecol Cancer. 2022;32:1497-1504.
    PubMed     Abstract available
    
    
    
95. BOHN JA, Fitch KC, Currier JJ, Bruegl A, et al
    HPV self-collection: what are we waiting for? Exploration of attitudes from frontline healthcare providers.
    Int J Gynecol Cancer. 2022;32:1519-1523.
    PubMed     Abstract available
    
    
    
96. GUANI B, Balaya V, Ayoubi JM, Feki A, et al
    Laparoscopic vaginal radical trachelectomy in the post-LACC era: step-by-step surgical procedure.
    Int J Gynecol Cancer. 2022;32:1617-1618.
    PubMed    
    
    
    November 2022
97. DZINAMARIRA T, Moyo E, Dzobo M, Mbunge E, et al
    Cervical cancer in sub-Saharan Africa: an urgent call for improving accessibility and use of preventive services.
    Int J Gynecol Cancer. 2022 Nov 11. pii: ijgc-2022-003957.
    PubMed     Abstract available
    
    
    
98. OYMAK E, Guler OC, Onal C
    Prognostic significance of albumin and globulin levels in cervical cancer patients treated with chemoradiotherapy.
    Int J Gynecol Cancer. 2022 Nov 10. pii: ijgc-2022-003768.
    PubMed     Abstract available
    
    
    
99. SALVO G, Ramalingam P, Bhosale P, Frumovitz M, et al
    Advanced stage (FIGO IVB) neuroendocrine cervical carcinoma.
    Int J Gynecol Cancer. 2022;32:1469-1474.
    PubMed    
    
    
    
100. SELCUK I
     Correspondence on 'Simplified anatomical nomenclature of lateral female pelvic spaces' by Querleu et al.
     Int J Gynecol Cancer. 2022;32:1495.
     PubMed    
     
     
     
101. CHIVA L, Gonzalez-Rodriguez M, Tendobi C
     Locally advanced vulvar carcinoma diagnosed during cervical cancer screening.
     Int J Gynecol Cancer. 2022;32:1492.
     PubMed    
     
     
     
102. DOMINGO S, Balasubbaiah Y, Nyndala S, Garcia I, et al
     Surgical training and cervical screening in rural India hospitals.
     Int J Gynecol Cancer. 2022;32:1475-1476.
     PubMed    
     
     
     October 2022
103. DATTA GD, Mayrand MH, Glenn BA
     Correspondence on "The increasing incidence of stage IV cervical cancer in the USA: what factors are related?" by Francoeur et al.
     Int J Gynecol Cancer. 2022 Oct 28. pii: ijgc-2022-004066.
     PubMed    
     
     
     
104. MONK BJ, Tan DSP, Hernandez Chagui JD, Takyar J, et al
     Proportions and incidence of locally advanced cervical cancer: a global systematic literature review.
     Int J Gynecol Cancer. 2022 Oct 14. pii: ijgc-2022-003801.
     PubMed     Abstract available
     
     
     
105. GAO H, Wu H, Zhang Y, Chen Z, et al
     Locoregional therapy for oligometastatic cervical cancer: a single-center retrospective study.
     Int J Gynecol Cancer. 2022 Oct 13. pii: ijgc-2022-003620.
     PubMed     Abstract available
     
     
     
106. TON M, Swami N, Germar MJV, Dee EC, et al
     HPV mRNA testing in cervical cancer screening: implications for low- and middle-income countries.
     Int J Gynecol Cancer. 2022 Oct 11. pii: ijgc-2022-003959.
     PubMed    
     
     
     
107. KOTHA NV, Williamson CW, Marra KV, McHale M, et al
     Incomplete cisplatin regimens in chemoradiation and its effect on outcomes for locally advanced cervical cancer.
     Int J Gynecol Cancer. 2022 Oct 6. pii: ijgc-2022-003766.
     PubMed     Abstract available
     
     
     
108. ROY M, Finch L, Kwon D, Jordan SE, et al
     Factors contributing to delays in initiation of front-line cervical cancer therapy: disparities in a diverse south Florida population.
     Int J Gynecol Cancer. 2022 Oct 5. pii: ijgc-2022-003475.
     PubMed     Abstract available
     
     
     
109. RODRIGUEZ J, Viveros-Carreno D, Pareja R
     Adjuvant treatment after radical surgery for cervical cancer with intermediate risk factors: is it time for an update?
     Int J Gynecol Cancer. 2022;32:1219-1226.
     PubMed     Abstract available
     
     
     
110. BORIA F, Chiva L, Chacon E, Zanagnolo V, et al
     SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer.
     Int J Gynecol Cancer. 2022;32:1236-1243.
     PubMed     Abstract available
     
     
     September 2022
111. CALO C, Barrington DA, Mclaughlin EM, Bixel K, et al
     Help wanted: low provider density is associated with advanced stage cervical cancer.
     Int J Gynecol Cancer. 2022 Sep 28. pii: ijgc-2022-003779.
     PubMed     Abstract available
     
     
     
112. CAPISTRANO I R, Paul S, Boere I, Pantziarka P, et al
     Drug repurposing as a potential source of innovative therapies in cervical cancer.
     Int J Gynecol Cancer. 2022 Sep 22. pii: ijgc-2022-003585.
     PubMed     Abstract available
     
     
     
113. MARTINEZ A, Diaz-Feijoo B, Querleu D
     Para-aortic lymphadenectomy in cervical cancer deserves a new trial.
     Int J Gynecol Cancer. 2022 Sep 16. pii: ijgc-2022-003910.
     PubMed    
     
     
     
114. CIBULA D, Borcinova M, Kocian R, Feltl D, et al
     CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16).
     Int J Gynecol Cancer. 2022 Sep 13. pii: ijgc-2022-003918.
     PubMed     Abstract available
     
     
     
115. CIBULA D
     Early-stage intermediate-risk-the group with the most heterogenous management among patients with cervical cancer.
     Int J Gynecol Cancer. 2022 Sep 13. pii: ijgc-2022-003908.
     PubMed    
     
     
     August 2022
116. GLICKMAN A, Diaz-Feijoo B, Agusti N, Carreras-Dieguez N, et al
     Laparoscopically assisted radical vaginal hysterectomy in early-stage cervical cancer.
     Int J Gynecol Cancer. 2022 Aug 22. pii: ijgc-2022-003670.
     PubMed    
     
     
     
117. FRANCOEUR AA, Liao CI, Casear MA, Chan A, et al
     The increasing incidence of stage IV cervical cancer in the USA: what factors are related?
     Int J Gynecol Cancer. 2022 Aug 18. pii: ijgc-2022-003728.
     PubMed     Abstract available
     
     
     
118. NOBREGA L, Zanon JR, Andrade CEEMDC, Schmidt RL, et al
     Prognostic role of hydronephrosis in the treatment of patients with locally advanced cervical cancer: a retrospective cohort.
     Int J Gynecol Cancer. 2022 Aug 16. pii: ijgc-2022-003679.
     PubMed     Abstract available
     
     
     July 2022
119. TENDOBI C, Fernandez-Marques M, Carlos S, Amann M, et al
     Validation of a sustainable internationally monitored cervical cancer screening system using a visual smartphone inspection in Kinshasa, Democratic Republic of Congo.
     Int J Gynecol Cancer. 2022 Jul 20. pii: ijgc-2022-003592.
     PubMed     Abstract available
     
     
     
120. HUEPENBECKER S, Santia MC, Harrison R, Dos Reis R, et al
     Impact of timing of urinary catheter removal on voiding dysfunction after radical hysterectomy for early cervical cancer.
     Int J Gynecol Cancer. 2022 Jul 8. pii: ijgc-2022-003654.
     PubMed     Abstract available
     
     
     
121. NASIOUDIS D, Rush M, Taunk NK, Ko EM, et al
     Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation.
     Int J Gynecol Cancer. 2022;32:823-827.
     PubMed     Abstract available
     
     
     
122. PAREJA R
     Surgical staging for locally-advanced cervical cancer: the answer remains 'NO'.
     Int J Gynecol Cancer. 2022;32:828-829.
     PubMed    
     
     
     
123. TOWNER M, Kim JJ, Simon MA, Matei D, et al
     Disparities in gynecologic cancer incidence, treatment, and survival: a narrative review of outcomes among black and white women in the United States.
     Int J Gynecol Cancer. 2022;32:931-938.
     PubMed     Abstract available
     
     
     June 2022
124. PFAENDLER KS, Williams HJ
     Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy.
     Int J Gynecol Cancer. 2022;32:815-816.
     PubMed    
     
     
     
125. WAGNER A, Skof AS, Sehouli J, Richter R, et al
     Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study.
     Int J Gynecol Cancer. 2022;32:716-723.
     PubMed     Abstract available
     
     
     
126. CHIKAZAWA K, Imai K, Kuwata T, Konno R, et al
     Importance of conization and pathological status.
     Int J Gynecol Cancer. 2022;32:820.
     PubMed    
     
     
     May 2022
127. SANSON C, Zaccarini F, Majer M, Pautier P, et al
     Neoadjuvant chemotherapy in fertility-sparing management of FIGO 2018 stage IB2 cervical cancer.
     Int J Gynecol Cancer. 2022;32:680-685.
     PubMed    
     
     
     April 2022
128. OLTHOF EP, Wenzel H, van der Velden J, Spijkerboer AM, et al
     Treatment of bulky lymph nodes in locally advanced cervical cancer: boosting versus debulking.
     Int J Gynecol Cancer. 2022 Apr 28. pii: ijgc-2022-003357.
     PubMed     Abstract available
     
     
     
129. GARCIA-DURAN C, Grau F, Villacampa G, Oaknin A, et al
     ATOMICC trial: a randomized, open-label, phase II trial of anti-PD1, dostarlimab, as maintenance therapy for patients with high-risk locally advanced cervical cancer after chemoradiation.
     Int J Gynecol Cancer. 2022 Apr 20. pii: ijgc-2022-003370.
     PubMed     Abstract available
     
     
     
130. KOTHA NV, Williamson CW, Mell LK, Murphy JD, et al
     Disparities in time to start of definitive radiation treatment for patients with locally advanced cervical cancer.
     Int J Gynecol Cancer. 2022 Apr 15. pii: ijgc-2021-003305.
     PubMed     Abstract available
     
     
     
131. TOBONI MD, Cohen A, Gentry ZL, Ostby SA, et al
     Sociodemographic characteristics and cervical cancer survival in different regions of the United States: a National Cancer Database study.
     Int J Gynecol Cancer. 2022 Apr 15. pii: ijgc-2021-003227.
     PubMed     Abstract available
     
     
     
132. 
     Correction: Human papillomavirus-independent cervical cancer: what are the implications?
     Int J Gynecol Cancer. 2022;32:582.
     PubMed    
     
     
     
133. GLENNON K, Treacy A, Geoghegan T, Downey P, et al
     Endocervical adenocarcinoma in situ with ovarian metastases.
     Int J Gynecol Cancer. 2022;32:566-569.
     PubMed    
     
     
     
134. ANGELES MA, Bizzarri N, Shushkevich A, Gomez-Hidalgo NR, et al
     Interviews from the European Society of Gynaecological Oncology 2021 Congress: an IJGC-ENYGO Fellows compilation.
     Int J Gynecol Cancer. 2022;32:468-473.
     PubMed    
     
     
     
135. AGUSTI N, Zorrilla Vaca A, Segarra-Vidal B, Iniesta MD, et al
     Outcomes of open radical hysterectomy following implementation of an enhanced recovery after surgery program.
     Int J Gynecol Cancer. 2022;32:480-485.
     PubMed     Abstract available
     
     
     March 2022
136. LEE J, Lin JB, Chang CL, Jan YT, et al
     Optimal prophylactic para-aortic radiotherapy in locally advanced cervical cancer: anatomy-based versus margin-based delineation.
     Int J Gynecol Cancer. 2022 Mar 30. pii: ijgc-2021-003298.
     PubMed     Abstract available
     
     
     
137. LI D, Huang S, Liu K, Qin Y, et al
     Clinicopathological characteristics and survival outcomes in human papillomavirus independent cervical cancer: a propensity score matched analysis.
     Int J Gynecol Cancer. 2022 Mar 24. pii: ijgc-2021-003159.
     PubMed     Abstract available
     
     
     
138. GRACE L, Sanday K, Garrett A, Land R, et al
     Vaginal vault smear cytology in detection of recurrence after hysterectomy for early cervical cancer.
     Int J Gynecol Cancer. 2022 Mar 14. pii: ijgc-2021-003302.
     PubMed     Abstract available
     
     
     
139. MAYADEV JS, Ke G, Mahantshetty U, Pereira MD, et al
     Global challenges of radiotherapy for the treatment of locally advanced cervical cancer.
     Int J Gynecol Cancer. 2022;32:436-445.
     PubMed     Abstract available
     
     
     
140. SHERER MV, Kotha NV, Williamson C, Mayadev J, et al
     Advances in immunotherapy for cervical cancer: recent developments and future directions.
     Int J Gynecol Cancer. 2022;32:281-287.
     PubMed     Abstract available
     
     
     
141. STURDZA AE, Knoth J
     Image-guided brachytherapy in cervical cancer including fractionation.
     Int J Gynecol Cancer. 2022;32:273-280.
     PubMed     Abstract available
     
     
     
142. MIRIYALA R, Mahantshetty U, Maheshwari A, Gupta S, et al
     Neoadjuvant chemotherapy followed by surgery in cervical cancer: past, present and future.
     Int J Gynecol Cancer. 2022;32:260-265.
     PubMed     Abstract available
     
     
     
143. TSENG M, Ngoi NY, Tan DS, Tong PS, et al
     Combined modality management of advanced cervical cancer including novel sensitizers.
     Int J Gynecol Cancer. 2022;32:246-259.
     PubMed     Abstract available
     
     
     
144. PINTO PJJ, Chen MJ, Santos Neto E, Faloppa CC, et al
     Prognostic factors in locally advanced cervical cancer with pelvic lymph node metastasis.
     Int J Gynecol Cancer. 2022;32:239-245.
     PubMed     Abstract available
     
     
     
145. CHOU B, Prasad Venkatesulu B, Coleman RL, Harkenrider M, et al
     Management of stage I and II cervical cancer: a review.
     Int J Gynecol Cancer. 2022;32:216-224.
     PubMed     Abstract available
     
     
     
146. FENLON JB, Rositch AF, Dickey BL, Kimani S, et al
     Gynecological radiotherapy in people living with human immunodeficiency virus: a semi-systematic literature review.
     Int J Gynecol Cancer. 2022;32:429-435.
     PubMed     Abstract available
     
     
     
147. BHATIA R, Lichter KE, Gurram L, MacDuffie E, et al
     The state of gynecologic radiation therapy in low- and middle-income countries.
     Int J Gynecol Cancer. 2022;32:421-428.
     PubMed     Abstract available
     
     
     
148. ZHOU Y, Espenel S, Achkar S, Leary A, et al
     Combined modality including novel sensitizers in gynecological cancers.
     Int J Gynecol Cancer. 2022;32:389-401.
     PubMed     Abstract available
     
     
     
149. DONOVAN EK, Covens AL, Kupets RS, Leung EW, et al
     The role of oophoropexy in patients with gynecological cancer who need radiation therapy.
     Int J Gynecol Cancer. 2022;32:380-388.
     PubMed     Abstract available
     
     
     
150. KIDD EA
     Imaging to optimize gynecological radiation oncology.
     Int J Gynecol Cancer. 2022;32:358-365.
     PubMed     Abstract available
     
     
     
151. JHINGRAN A
     Updates in the treatment of vaginal cancer.
     Int J Gynecol Cancer. 2022;32:344-351.
     PubMed     Abstract available
     
     
     
152. HSU IC, Yoshida E
     Ultrasound guidance for cervical implantation.
     Int J Gynecol Cancer. 2022;32:266-272.
     PubMed     Abstract available
     
     
     
153. FRANCO I, Viswanathan AN
     Radiation oncology management of stage III and IVA cervical carcinoma.
     Int J Gynecol Cancer. 2022;32:231-238.
     PubMed     Abstract available
     
     
     
154. CHOPRA S, Ranjan N, Mittal P
     Postoperative adjuvant radiation for cervix cancer: reflections on the evidence and a peep into the future.
     Int J Gynecol Cancer. 2022;32:225-230.
     PubMed     Abstract available
     
     
     February 2022
155. VIVEROS-CARRENO D, Rodriguez J, Rendon Pereira GJ, Slama J, et al
     Fertility-sparing surgery after neo-adjuvant chemotherapy in women with cervical cancer larger than 4 cm: a systematic review.
     Int J Gynecol Cancer. 2022 Feb 24. pii: ijgc-2021-003297.
     PubMed     Abstract available
     
     
     
156. MACCHIA G, Nardangeli A, Laliscia C, Fodor A, et al
     Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups.
     Int J Gynecol Cancer. 2022 Feb 22. pii: ijgc-2021-003237.
     PubMed     Abstract available
     
     
     
157. REGAUER S, Reich O, Kashofer K
     Correspondence on "Human papillomavirus-independent cervical cancer" by Fernandes et al.
     Int J Gynecol Cancer. 2022 Feb 15. pii: ijgc-2022-003368.
     PubMed    
     
     
     
158. TONINI F, Michel D, Foulon A
     An unusual cause of cervical bleeding.
     Int J Gynecol Cancer. 2022;32:214.
     PubMed    
     
     
     
159. CHACON E, Manzour N, Zanagnolo V, Querleu D, et al
     SUCCOR cone study: conization before radical hysterectomy.
     Int J Gynecol Cancer. 2022;32:117-124.
     PubMed     Abstract available
     
     
     
160. NASIOUDIS D, Ramirez PT
     Is prior conization the way forward to determine surgical approach? The answer is not so simple!
     Int J Gynecol Cancer. 2022;32:125-126.
     PubMed    
     
     
     
161. SERRA RUBERT A, Climent MT, Llueca Abella A
     Schauta, an old technique for a new discussion.
     Int J Gynecol Cancer. 2022;32:205-206.
     PubMed    
     
     
     January 2022
162. ILHAN Y, Tatli AM, Teker F, Onder AH, et al
     Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer.
     Int J Gynecol Cancer. 2022 Jan 27. pii: ijgc-2021-003165.
     PubMed     Abstract available
     
     
     
163. DREYER G, Botha MH, Snyman LC, Visser C, et al
     Combining cervical cancer screening for mothers with schoolgirl vaccination during human papillomavirus (HPV) vaccine implementation in South Africa: results from the VACCS1 and VACCS2 trials.
     Int J Gynecol Cancer. 2022 Jan 25. pii: ijgc-2021-003079.
     PubMed     Abstract available
     
     
     
164. IJFF M, Crezee J, Oei AL, Stalpers LJA, et al
     The role of hyperthermia in the treatment of locally advanced cervical cancer: a comprehensive review.
     Int J Gynecol Cancer. 2022 Jan 19. pii: ijgc-2021-002473.
     PubMed     Abstract available
     
     
     
165. BIZZARRI N, Pletnev A, Razumova Z, Zalewski K, et al
     Quality of training in cervical cancer radical surgery: a survey from the European Network of Young Gynaecologic Oncologists (ENYGO).
     Int J Gynecol Cancer. 2022 Jan 6. pii: ijgc-2021-002812.
     PubMed     Abstract available
     
     
     
166. PEREZ MONTIEL CA, Varela Aguirre GJ
     Primary non-gestational choriocarcinoma of the uterine cervix.
     Int J Gynecol Cancer. 2022;32:111-112.
     PubMed    
     
     
     
167. GORDHANDAS SB, Kahn R, Sassine D, Aviki EM, et al
     Gastric-type adenocarcinoma of the cervix in patients with Peutz-Jeghers syndrome: a systematic review of the literature with proposed screening guidelines.
     Int J Gynecol Cancer. 2022;32:79-88.
     PubMed     Abstract available
     
     
     
168. DAIX M, Angeles MA, Leray H, Vergriete K, et al
     Anterior pelvic exenteration and laterally extended pelvic resection: a step by step procedure.
     Int J Gynecol Cancer. 2022;32:107-108.
     PubMed    
     
     
     
169. DEVAJA O, Papadopoulos AJ, Bharathan R, Montalto SA, et al
     Sentinel lymph node biopsy alone in the management of early cervical carcinoma.
     Int J Gynecol Cancer. 2022;32:15-20.
     PubMed     Abstract available
     
     
     December 2021
170. RODRIGUES AN, de Melo AC, Calabrich AFC, Cronenberger E, et al
     Characteristics of patients diagnosed with cervical cancer in Brazil: preliminary results of the prospective cohort EVITA study (EVA001/LACOG 0215).
     Int J Gynecol Cancer. 2021 Dec 29. pii: ijgc-2021-002972.
     PubMed     Abstract available
     
     
     
171. DARIN MC, Di Guilmi J, Quiroga Luna J, Maya AG, et al
     Cervical cancer after LACC: a combination of surgical strategies.
     Int J Gynecol Cancer. 2021 Dec 16. pii: ijgc-2021-003042.
     PubMed    
     
     
     
172. BOHN JA, Hernandez-Zepeda ML, Hersh AR, Munro EG, et al
     Does obesity influence the preferred treatment approach for early-stage cervical cancer? A cost-effectiveness analysis.
     Int J Gynecol Cancer. 2021 Dec 9. pii: ijgc-2021-003004.
     PubMed     Abstract available
     
     
     
173. 
     Correction: Cervical cancer in pregnancy at various gestational ages.
     Int J Gynecol Cancer. 2021;31:1624.
     PubMed    
     
     
     November 2021
174. SCHMELER KM, Batman SH
     Human papillomavirus-independent cervical cancer: what are the implications?
     Int J Gynecol Cancer. 2021 Nov 29. pii: ijgc-2021-003250.
     PubMed    
     
     
     
175. POUYEZ C, Dami M
     Gallstone mimicking metastatic cervical cancer.
     Int J Gynecol Cancer. 2021;31:1496.
     PubMed    
     
     
     
176. FERNANDES A, Viveros-Carreno D, Hoegl J, Avila M, et al
     Human papillomavirus-independent cervical cancer.
     Int J Gynecol Cancer. 2021 Nov 1. pii: ijgc-2021-003014.
     PubMed     Abstract available
     
     
     
177. HARRY V, Persad S, Barrow T, Rattan R, et al
     UK-trained specialists perform first radical trachelectomy in Trinidad and Tobago.
     Int J Gynecol Cancer. 2021;31:1486-1487.
     PubMed    
     
     
     October 2021
178. LI J, Gu C, Zheng H, Geng X, et al
     Ultrasonographic diagnosis in rare primary cervical cancer.
     Int J Gynecol Cancer. 2021 Oct 28. pii: ijgc-2021-002860.
     PubMed     Abstract available
     
     
     
179. VIVEROS-CARRENO D, Rodriguez J, Pareja R
     Incidence of metastasis in circumflex iliac nodes in patients with cervical cancer: a systematic review.
     Int J Gynecol Cancer. 2021 Oct 7. pii: ijgc-2021-003005.
     PubMed     Abstract available
     
     
     
180. 
     Correction: Infection versus cancer: management of actinomyces mimicking cervical cancer or ovarian cancer.
     Int J Gynecol Cancer. 2021;31:1400.
     PubMed    
     
     
     
181. SOZZI G, Chiantera V
     Vena cava resection and bypass for recurrent cervical cancer.
     Int J Gynecol Cancer. 2021;31:1393.
     PubMed    
     
     
     
182. ODETTO D, Saadi JM, Chacon CB, Wernicke A, et al
     Uterine transposition after radical trachelectomy.
     Int J Gynecol Cancer. 2021;31:1374-1379.
     PubMed    
     
     
     
183. LERAY H, Angeles MA, Daix M, Martinez A, et al
     How to avoid peritoneal tumor spillage during total abdominal hysterectomy in uterine cancers with cervical invasion.
     Int J Gynecol Cancer. 2021;31:1382-1383.
     PubMed    
     
     
     September 2021
184. DATTA A, West C, O'Connor JPB, Choudhury A, et al
     Impact of hypoxia on cervical cancer outcomes.
     Int J Gynecol Cancer. 2021 Sep 30. pii: ijgc-2021-002806.
     PubMed     Abstract available
     
     
     
185. ABU-RUSTUM NR
     ConCerv: a prospective trial of conservative surgery for low-risk early stage cervical cancer, by Schmeler et al.
     Int J Gynecol Cancer. 2021 Sep 24. pii: ijgc-2021-003008.
     PubMed    
     
     
     
186. SCHMELER KM, Pareja R, Lopez Blanco A, Humberto Fregnani J, et al
     ConCerv: a prospective trial of conservative surgery for low-risk early-stage cervical cancer.
     Int J Gynecol Cancer. 2021 Sep 7. pii: ijgc-2021-002921.
     PubMed     Abstract available
     
     
     August 2021
187. LUVIAN-MORALES J, Flores-Cisneros L, Jimenez-Lima R, Alarcon-Barrios S, et al
     Validation of the QLQ-CX24 questionnaire for the assessment of quality of life in Mexican women with cervical cancer.
     Int J Gynecol Cancer. 2021 Aug 5. pii: ijgc-2021-002720.
     PubMed     Abstract available
     
     
     
188. SALVO G, Ramalingam P, Bhosale P, Frumovitz M, et al
     Early-stage, high-grade neuroendocrine cervical carcinoma.
     Int J Gynecol Cancer. 2021;31:1179-1183.
     PubMed    
     
     
     
189. NASIOUDIS D, Byrne M, Ko EM, Haggerty AF, et al
     Minimally invasive hysterectomy for stage IA cervical carcinoma: a survival analysis of the National Cancer Database.
     Int J Gynecol Cancer. 2021;31:1099-1103.
     PubMed     Abstract available
     
     
     July 2021
190. BORIA F, Chiva L, Zanagnolo V, Querleu D, et al
     Radical hysterectomy in early cervical cancer in Europe: characteristics, outcomes and evaluation of ESGO quality indicators.
     Int J Gynecol Cancer. 2021 Jul 28. pii: ijgc-2021-002587.
     PubMed     Abstract available
     
     
     
191. GROVER S, Ning MS, Bale M, Lichter KE, et al
     Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus.
     Int J Gynecol Cancer. 2021 Jul 26. pii: ijgc-2021-002601.
     PubMed     Abstract available
     
     
     
192. SPENCER NM, Bos L
     Intracardiac metastatic cervical cancer.
     Int J Gynecol Cancer. 2021;31:1095.
     PubMed    
     
     
     
193. NASIOUDIS D, Albright BB, Ko EM, Haggerty AF, et al
     Oncologic outcomes of minimally invasive versus open radical hysterectomy for early stage cervical carcinoma and tumor size <2 cm: a systematic review and meta-analysis.
     Int J Gynecol Cancer. 2021;31:983-990.
     PubMed     Abstract available
     
     
     June 2021
194. CHILINDA G, Massamba L, Meja S, Ngo C, et al
     Implementing a comprehensive cervical cancer program in Southern Malawi: a 'Medecins Sans Frontieres', Ministry of Health, and College of Medicine of Blantyre Collaborative Project.
     Int J Gynecol Cancer. 2021 Jun 2. pii: ijgc-2021-002743.
     PubMed    
     
     
     
195. NASIOUDIS D, Latif NA, Giuntoli Ii RL, Haggerty AF, et al
     Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors.
     Int J Gynecol Cancer. 2021;31:829-834.
     PubMed     Abstract available
     
     
     May 2021
196. MANZOUR N, Vazquez-Vicente D, Carriles I, Boria F, et al
     Intra-operative radiation therapy after a total lateral extended infralevator exenteration for recurrent cervical cancer.
     Int J Gynecol Cancer. 2021 May 24. pii: ijgc-2021-002592.
     PubMed    
     
     
     
197. MATSUO K, Nusbaum DJ, Matsuzaki S, Klar M, et al
     Utilization and outcomes of adjuvant systemic chemotherapy alone in high risk, early stage cervical cancer in the United States.
     Int J Gynecol Cancer. 2021 May 20. pii: ijgc-2021-002655.
     PubMed     Abstract available
     
     
     
198. KUMAR D, Miriyala R, Rai B, Bansal P, et al
     Impact of three-dimensional chemoradiation on pelvic bone mineral density, low back pain, and disability in cervical cancer: a prospective study.
     Int J Gynecol Cancer. 2021 May 11. pii: ijgc-2020-002290.
     PubMed     Abstract available
     
     
     
199. WRIGHT JD
     Minimal risk for minimally invasive hysterectomy for stage IA cervical cancer?
     Int J Gynecol Cancer. 2021 May 10. pii: ijgc-2021-002733.
     PubMed    
     
     
     
200. GOMEZ RODRIGO S, Calderon J, Dionisi JN, Santi A, et al
     Cervical cancer in pregnancy at various gestational ages.
     Int J Gynecol Cancer. 2021;31:784-788.
     PubMed    
     
     
     
201. NAVARRO AS, Angeles MA, Migliorelli F, Illac C, et al
     Comparison of SPECT-CT with intraoperative mapping in cervical and uterine malignancies.
     Int J Gynecol Cancer. 2021;31:679-685.
     PubMed     Abstract available
     
     
     
202. MUALLEM MZ, Miranda A, Muallem J
     Nerve-sparing radical hysterectomy-Muallem technique with explanation of parametrium and paracolpium anatomy.
     Int J Gynecol Cancer. 2021;31:795-796.
     PubMed    
     
     
     April 2021
203. MAENE C, Salihi RR, Van Nieuwenhuysen E, Han SN, et al
     Combination of weekly paclitaxel-carboplatin plus standard bevacizumab as neoadjuvant treatment in stage IB-IIB cervical cancer.
     Int J Gynecol Cancer. 2021 Apr 15. pii: ijgc-2021-002432.
     PubMed     Abstract available
     
     
     
204. CORINTI M, Alvarenga-Bezerra V, Ribeiro R, Liao AW, et al
     Extraperitoneal laparoscopic pelvic lymphadenectomy for cervical cancer staging in twin pregnancy.
     Int J Gynecol Cancer. 2021 Apr 13. pii: ijgc-2021-002410.
     PubMed    
     
     
     
205. CHEN JH, Duan H, Yu XB, Zhao HW, et al
     Clinical features and prognostic factors of cervical villoglandular adenocarcinoma.
     Int J Gynecol Cancer. 2021;31:512-517.
     PubMed     Abstract available
     
     
     March 2021
206. CIBULA D
     Rationale for the avoidance of parametrectomy and systematic lymphadenectomy in patients with early stages of neuroendocrine cervical cancer.
     Int J Gynecol Cancer. 2021 Mar 18. pii: ijgc-2021-002510.
     PubMed    
     
     
     
207. SORMANI J, Datchoua AM, Petignat P, Kenfack B, et al
     Effects of the COVID-19 pandemic on an urban cervical cancer screening program in West Cameroon.
     Int J Gynecol Cancer. 2021 Mar 12. pii: ijgc-2021-002555.
     PubMed    
     
     
     
208. FURUSAWA A, Takekuma M, Mori K, Usami T, et al
     A randomized phase III trial of adjuvant chemotherapy versus concurrent chemoradiotherapy for postoperative cervical cancer: Japanese Gynecologic Oncology Group study (JGOG1082).
     Int J Gynecol Cancer. 2021 Mar 4. pii: ijgc-2020-002344.
     PubMed     Abstract available
     
     
     
209. LOPEZ A, Rodriguez J, Estrada E, Aragona A, et al
     Neoadjuvant chemotherapy in pregnant patients with cervical cancer: a Latin-American multicenter study.
     Int J Gynecol Cancer. 2021;31:468-474.
     PubMed     Abstract available
     
     
     
210. MARTINELLI F, Ditto A, Filippi F, Vinti D, et al
     Conization and lymph node evaluation as a fertility-sparing treatment for early stage cervical cancer.
     Int J Gynecol Cancer. 2021;31:457-461.
     PubMed     Abstract available
     
     
     
211. FANFANI F, Pedone Anchora L, Di Martino G, Bizzarri N, et al
     Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer.
     Int J Gynecol Cancer. 2021;31:452-456.
     PubMed     Abstract available
     
     
     
212. NICA A, Marchocki Z, Gien LT, Kupets R, et al
     Cervical conization and lymph node assessment for early stage low-risk cervical cancer.
     Int J Gynecol Cancer. 2021;31:447-451.
     PubMed     Abstract available
     
     
     
213. NOLL F, Palacios Torres AT, Pecci P, Lucchini SM, et al
     Neoadjuvant chemotherapy in early-stage cervical cancer (<2 cm) before conization for fertility preservation: is there any advantage over upfront conization?
     Int J Gynecol Cancer. 2021;31:379-386.
     PubMed     Abstract available
     
     
     
214. BUONOMO B, Multinu F, Casarin J, Betella I, et al
     Ovarian transposition in patients with cervical cancer prior to pelvic radiotherapy: a systematic review.
     Int J Gynecol Cancer. 2021;31:360-370.
     PubMed     Abstract available
     
     
     
215. DOGAN NU, Kohler C, Pfiffer T, Plaikner A, et al
     Prospective assessment of urinary and bowel symptoms, and sexual function between laparoscopic assisted vaginal radical trachelectomy and radical hysterectomy.
     Int J Gynecol Cancer. 2021;31:484-489.
     PubMed     Abstract available
     
     
     
216. BAIOCCHI G, Vieira M, Moretti-Marques R, Mantoan H, et al
     Uterine transposition for gynecological cancers.
     Int J Gynecol Cancer. 2021;31:442-446.
     PubMed     Abstract available
     
     
     
217. BURBANO J, Heredia F, Sanabria D, Ardila EG, et al
     Neoadjuvant chemotherapy prior to fertility-sparing surgery in cervical tumors larger than 2 cm: a systematic review on fertility and oncologic outcomes.
     Int J Gynecol Cancer. 2021;31:387-398.
     PubMed     Abstract available
     
     
     
218. STEWART K, Campbell S, Frumovitz M, Ramirez PT, et al
     Fertility considerations prior to conservative management of gynecologic cancers.
     Int J Gynecol Cancer. 2021;31:339-344.
     PubMed     Abstract available
     
     
     
219. MORO F, Bonanno GM, Gui B, Scambia G, et al
     Imaging modalities in fertility preservation in patients with gynecologic cancers.
     Int J Gynecol Cancer. 2021;31:323-331.
     PubMed     Abstract available
     
     
     February 2021
220. CAMPITELLI M, Lazzari R, Piccolo F, Ferrazza P, et al
     Brachytherapy or external beam radiotherapy as a boost in locally advanced cervical cancer: a Gynaecology Study Group in the Italian Association of Radiation and Clinical Oncology (AIRO) review.
     Int J Gynecol Cancer. 2021 Feb 25. pii: ijgc-2020-002310.
     PubMed     Abstract available
     
     
     
221. MCCORMACK M, Gaffney D, Tan D, Bennet K, et al
     The Cervical Cancer Research Network (Gynecologic Cancer InterGroup) roadmap to expand research in low- and middle-income countries.
     Int J Gynecol Cancer. 2021 Feb 25. pii: ijgc-2021-002422.
     PubMed     Abstract available
     
     
     
222. SCOTT AA, Yarney J, Vanderpuye V, Akoto Aidoo C, et al
     Outcomes of patients with cervical cancer treated with low- or high-dose rate brachytherapy after concurrent chemoradiation.
     Int J Gynecol Cancer. 2021 Feb 8. pii: ijgc-2020-002120.
     PubMed     Abstract available
     
     
     
223. STOLNICU S, Boros M, Hoang L, Almadani N, et al
     FIGO 2018 stage IB endocervical adenocarcinomas: an international study of outcomes informed by prognostic biomarkers.
     Int J Gynecol Cancer. 2021;31:177-184.
     PubMed     Abstract available
     
     
     January 2021
224. RODRIGUEZ J, Rauh-Hain JA, Saenz J, Isla DO, et al
     Oncological outcomes of laparoscopic radical hysterectomy versus radical abdominal hysterectomy in patients with early-stage cervical cancer: a multicenter analysis.
     Int J Gynecol Cancer. 2021 Jan 27. pii: ijgc-2020-002086.
     PubMed     Abstract available
     
     
     
225. LI L, Wu M
     Pelvic nerves during radical trachelectomy.
     Int J Gynecol Cancer. 2021;31:154.
     PubMed    
     
     
     
226. SAKURAGI N, Kaneuchi M
     Paracervical and paravaginal tissue dissection in the Okabayashi-Kobayashi radical hysterectomy and nerve-sparing technique.
     Int J Gynecol Cancer. 2021;31:145-146.
     PubMed    
     
     
     December 2020
227. CAO L, Wen H, Feng Z, Han X, et al
     Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
     Int J Gynecol Cancer. 2020 Dec 10. pii: ijgc-2020-001974.
     PubMed     Abstract available
     
     
     
228. KIM N, Choi SH, Chang JS, Kim YT, et al
     Use of bevacizumab before or after radiotherapy increases the risk of fistula formation in patients with cervical cancer.
     Int J Gynecol Cancer. 2020 Dec 3. pii: ijgc-2020-002031.
     PubMed     Abstract available
     
     
     
229. MARNITZ S, Tsunoda AT, Martus P, Vieira M, et al
     Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
     Int J Gynecol Cancer. 2020;30:1855-1861.
     PubMed     Abstract available
     
     
     November 2020
230. RENDON GJ, Lopez Blanco A, Aragona A, Saadi JM, et al
     Oncological and obstetrical outcomes after neo-adjuvant chemotherapy followed by fertility-sparing surgery in patients with cervical cancer >/=2 cm.
     Int J Gynecol Cancer. 2020 Nov 16. pii: ijgc-2020-002076.
     PubMed     Abstract available
     
     
     
231. OLTHOF EP, Mom CH, van der Velden J
     More attention is needed for the corrigendum to the revised FIGO staging for carcinoma of the cervix uteri.
     Int J Gynecol Cancer. 2020;30:1850.
     PubMed    
     
     
     October 2020
232. SANTORO A, Angelico G, Inzani F, Arciuolo D, et al
     Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer.
     Int J Gynecol Cancer. 2020 Oct 30. pii: ijgc-2020-001710.
     PubMed     Abstract available
     
     
     
233. SMALL W JR, Peltecu G, Puiu A, Corha A, et al
     Cervical cancer in Eastern Europe: review and proceedings from the Cervical Cancer Research Conference.
     Int J Gynecol Cancer. 2020 Oct 29. pii: ijgc-2020-001652.
     PubMed     Abstract available
     
     
     
234. PRECI DP, Almeida A, Weiler AL, Mukai Franciosi ML, et al
     Oxidative damage and antioxidants in cervical cancer.
     Int J Gynecol Cancer. 2020 Oct 27. pii: ijgc-2020-001587.
     PubMed     Abstract available
     
     
     
235. ALLANSON ER, Velanova V, Frazer IH, McAdam M, et al
     An update on cervical cancer screening in Vanuatu.
     Int J Gynecol Cancer. 2020 Oct 26. pii: ijgc-2020-002129.
     PubMed    
     
     
     
236. LIN F, Zheng R, Yu C, Su Y, et al
     Predictive role of serum cholesterol and triglycerides in cervical cancer survival.
     Int J Gynecol Cancer. 2020 Oct 13. pii: ijgc-2020-001333.
     PubMed     Abstract available
     
     
     
237. BERCOW AS, Nitecki R, Haber H, Gockley AA, et al
     Palliative care referral patterns and measures of aggressive care at the end of life in patients with cervical cancer.
     Int J Gynecol Cancer. 2020 Oct 12. pii: ijgc-2020-001812.
     PubMed     Abstract available
     
     
     
238. NICA A, Kim SR, Gien LT, Covens A, et al
     Survival after minimally invasive surgery in early cervical cancer: is the intra-uterine manipulator to blame?
     Int J Gynecol Cancer. 2020 Oct 9. pii: ijgc-2020-001816.
     PubMed     Abstract available
     
     
     
239. ANDERSEN B, Njor SH, Jensen AMS, Johansen T, et al
     HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study.
     Int J Gynecol Cancer. 2020 Oct 9. pii: ijgc-2020-001457.
     PubMed     Abstract available
     
     
     
240. HARRISON R, Ramirez PT
     Bronchocutaneous fistula from metastatic cervical cancer with COVID-19.
     Int J Gynecol Cancer. 2020 Oct 9. pii: ijgc-2020-001976.
     PubMed    
     
     
     
241. DE CUYPERE M, Lovinfosse P, Gennigens C, Hermesse J, et al
     Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography/computed tomography (PET/CT) predict survival in patients with locally advanced cervical cancer.
     Int J Gynecol Cancer. 2020 Oct 8. pii: ijgc-2020-001676.
     PubMed     Abstract available
     
     
     September 2020
242. GOVOROV I, Dikareva E, Velichko E, Kesic V, et al
     Human-machine alliance against cervical cancer.
     Int J Gynecol Cancer. 2020 Sep 30. pii: ijgc-2020-002064.
     PubMed    
     
     
     
243. GULTEKIN M, Beduk Esen CS, Balci B, Alanyali S, et al
     Role of vaginal brachytherapy boost following adjuvant external beam radiotherapy in cervical cancer: Turkish Society for Radiation Oncology Gynecologic Group Study (TROD 04-002).
     Int J Gynecol Cancer. 2020 Sep 30. pii: ijgc-2020-001733.
     PubMed     Abstract available
     
     
     
244. NAGASE Y, Kobayashi E, Takiuchi T, Kodama M, et al
     Challenges of laparoscopic lymphadenectomy for cervical cancer in pregnant women: techniques and tips.
     Int J Gynecol Cancer. 2020 Sep 30. pii: ijgc-2020-001703.
     PubMed    
     
     
     
245. TU H, Huang H, Xian B, Li J, et al
     Sentinel lymph node biopsy versus pelvic lymphadenectomy in early-stage cervical cancer: a multi-center randomized trial (PHENIX/CSEM 010).
     Int J Gynecol Cancer. 2020 Sep 24. pii: ijgc-2020-001857.
     PubMed     Abstract available
     
     
     May 2020
246. VAZQUEZ-VICENTE D, Castellanos T, Cabello A, Chacon E, et al
     Multidisciplinary approach in the pelvic relapse of a previously irradiated cervical tumor.
     Int J Gynecol Cancer. 2020;30:714.
     PubMed    
     
     
     
247. GULTEKIN M, Turan SH, Boztas G, Ozturk C, et al
     Passion for saving lives: Turkey between 2012 and 2017.
     Int J Gynecol Cancer. 2020;30:709-710.
     PubMed    
     
     
     
248. PAREJA R
     Safety of minimally invasive radical hysterectomy in cervical tumors <2 cm.
     Int J Gynecol Cancer. 2020;30:572-574.
     PubMed    
     
     
     April 2020
249. CHAMBERS LM, Herrmann A, Michener CM, Ferrando CA, et al
     Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinoma.
     Int J Gynecol Cancer. 2020;30:515-524.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.